The analysis of biodistribution and tumor uptake of [<sup>18</sup>F]AlF-FAPI-74 in patients with soft tissue sarcoma and gastro-intestinal tumors compared with [<sup>18</sup>F]FDG in a prospective, exploratory study. [PDF]
Novruzov E +13 more
europepmc +1 more source
This study uses tyrosinase, which is highly expressed in melanoma, to drive porphyrins to polymerize and self‐assemble within tumor cells to form retented microstructures. This process induces immunogenic death and activates immune responses (M1 macrophages, dendritic cells, CD8+T cells), turning “cold” tumors into “hot” tumors.
Mian Tang +9 more
wiley +1 more source
A sstR2-targeted radiohybrid theranostic agent for PET imaging and β<sup>-</sup> therapy with excellent preclinical performance. [PDF]
Deiser S +4 more
europepmc +1 more source
Engineering Oncolytic Virus‐Armed Macrophages for Enhanced Cancer Immunotherapy
ZIFOA‐M is engineered by conjugating oncolytic adenovirus‐loaded ZIF‐8 nanoparticles onto macrophage surfaces via bioorthogonal chemistry. Upon tumor infiltration, the platform releases OA to downregulate CD47/CD24 on tumor cells, restoring macrophage phagocytosis.
Jilong Wang +10 more
wiley +1 more source
Safety, efficacy, and distal nerve Schwann cell biodistribution in mice and NHPs to support translation of AAV9 RNAi therapy for CMT1A. [PDF]
Stavrou M +17 more
europepmc +1 more source
Engineered extracellular vesicles displaying Ephrin‐B2 selectively target Ephrin‐B4–expressing ovarian cancer cells, enabling precise delivery in patient‐derived models. This scalable bio‐manufacturing platform reveals a versatile strategy to exploit Ephrin signaling for highly specific therapeutic payload delivery and motivates exploration of tailored
Nihar Godbole +17 more
wiley +1 more source
Should patients with pre-existing anti-AAV antibodies be excluded from receiving intrathecally delivered AAV vectors? [PDF]
Gray SJ.
europepmc +1 more source
PD‐L1 is primarily expressed in renal tubules and upregulated in both murine models of AKI and renal biopsy samples from patients with AKI. PD‐L1 can promote adaptive TECs repair through interacting with BRCA1, independent of its canonical immunomodulatory function of T cells, and PD‐L1 supplementation may represent a promising therapeutic strategy for
Wei Jiang +17 more
wiley +1 more source
Chelator Conjugation Chemistry Matters: Squaramide Linker Enhances Tumor Contrast in <sup>68</sup>Ga-labeled Anti-CEA Nanobody Tracer. [PDF]
Saliën J +9 more
europepmc +1 more source

